<?xml version="1.0" encoding="UTF-8"?>
<p id="par0055">The current available clinical interventions for the treatment of these NDs are only palliatives with associated adverse effects [
 <xref rid="bib0075" ref-type="bibr">15</xref>], thus there is a need for a new, non-invasive, non-toxic and non-expensive treatment for the diseases. Phytochemicals and natural products of plant origin have been considered to have great beneficial effects to human health and help in the prevention and treatment of many diseases including neurodegenerative disorders [
 <xref rid="bib0080" ref-type="bibr">[16]</xref>, 
 <xref rid="bib0085" ref-type="bibr">[17]</xref>, 
 <xref rid="bib0090" ref-type="bibr">[18]</xref>]. 
 <italic>Vernonia amygdalina</italic> is medicinal plant used traditionally in the treatment and treatment of different diseases [
 <xref rid="bib0325" ref-type="bibr">65</xref>,
 <xref rid="bib0330" ref-type="bibr">66</xref>]. The documented phytochemical constituents of various fractions of 
 <italic>Vernonia amygdalina</italic> includes epivernodalol, sesquiterpene lactones, elemanolide [
 <xref rid="bib0095" ref-type="bibr">19</xref>], edotides [
 <xref rid="bib0100" ref-type="bibr">20</xref>], terpenes, steroids, coumarins, flavonoids, phenolic acids, lignans, xanthones and anthraquinone [
 <xref rid="bib0105" ref-type="bibr">21</xref>], saponins and alkaloids [
 <xref rid="bib0110" ref-type="bibr">22</xref>]. Documented pharmacological actions of these phytochemical constituents include antioxidant properties [
 <xref rid="bib0115" ref-type="bibr">23</xref>], anti-inflammatory [
 <xref rid="bib0120" ref-type="bibr">24</xref>].
</p>
